TerminatedNot applicableNCT02114606

Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge

Studying NON RARE IN EUROPE: Eosinophilic esophagitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of North Carolina, Chapel Hill
Principal Investigator
Evan Dellon, MD, MPH
UNC-Chapel Hill
Intervention
Cytosponge™ Cell Collection Device(device)
Enrollment
86 enrolled
Eligibility
18-80 years · All sexes
Timeline
20152016

Study locations (2)

Collaborators

Mayo Clinic · University of Cambridge · CURED Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02114606 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Eosinophilic esophagitis

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Eosinophilic esophagitis

← Back to all trials